Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic

Georg Pfeiler, Angela DeMichele, Amylou C. Dueck, Christian Fesl, Michael Gnant, Erica L. Mayer

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)195-197
Number of pages3
JournalThe Lancet Oncology
Issue number2
StatePublished - Feb 2022

ASJC Scopus subject areas

  • Oncology

Cite this